Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors is a research paper published in Molecular Therapy Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
University of Pittsburgh
Grant: R01-CA222804
NCI NIH HHS
Grant: R01 CA222804
National Institutes of Health
Grant: 5R01CA222804-03
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
National Institutes of Health
Fields of Study
Keywords